Month: July 2014

Medicines360, a non-profit women’s health pharmaceutical company, and Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Medicines360’s New Drug Application (NDA) for Levosert™ (levonorgestrel), a hormonal intrauterine contraceptive (IUC) for use by women to prevent pregnancy.

  • Posted in Press Releases
  • Comments Off on Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert™ IUD